| Zenda Technologies, the
latest company to form as the result of collaborative research efforts
between Georgia Tech and Emory University faculty, is developing a device
to evaluate mild cognitive impairment. The DETECT system was invented
by Georgia Tech/Emory Center for the Engineering of Living Tissues (GTEC)
biomedical engineering faculty member Dr. Michelle LaPlaca and Dr. David
Wright, an MD from the Emory University School of Medicine, Emergency Medicine
Research Center.
The DETECT system may be
used in the early detection of Alzheimer’s disease and is expected to be
a cost- and time-effective replacement for the existing pen-and-paper cognitive
function tests. Clinical testing is underway and the company expects
to have the first commercial device on the market in early 2009.
Zenda is also exploring additional applications for the DETECT system including
evaluating Attention Deficit/Hyperactivity Disorder (AD/HD) as well as
mild concussion resulting from high-impact sports or battlefield injuries.
The company is led by CEO and President Lawrence Catchpole. |
